Two important concepts will be introduced:
🔸 Safety-and-Sustainability-by-design – a cornerstone for sustainable innovation by Susanne Resch, BNN (BioNanoNet ForschungsGmbH), Austria and
Open innovation test beds – their role on the way to the market by two existing infrastructures:
🔸 PHOENIX – Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products (10 minutes)
Scientific Coordinator Dr. Nazende Günday-Türeli, MyBiotech GmbH, Germany
🔸 NextGenMicrofluidics – Next generation test bed for upscaling of microfluidic devices based on nano-enabled surfaces and membranes (10 minutes)
Scientific Coordinator Dr. Martin Smolka, JOANNEUM RESEARCH ForschungsGmbH, Austria
It will be followed by the 🔸 panel discussion moderated by Andreas Falk, CEO of BNN.
From idea to reality - important cornerstones on the way to the (nano)market
By Susanne Resch Research Scientist at BNN, Andreas Falk CEO of BNN, Nazende Günday-Türeli Scientific Coordinator at MyBiotech GmbH
Two important concepts will be introduced: Safety-and-Sustainability-by-design - a cornerstone for sustainable innovation by Susanne Resch, BNN (BioNanoNet ForschungsGmbH), Austria and Open innovation test beds - their role on the way to the market by two existing infrastructures: - PHOENIX - Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products (10 minutes) Scientific Coordinator Dr. Nazende Günday-Türeli, MyBiotech GmbH, Germany - NextGenMicrofluidics - Next generation test bed for upscaling of microfluidic devices based on nano-enabled surfaces and membranes (10 minutes) Scientific Coordinator Dr. Martin Smolka, JOANNEUM RESEARCH ForschungsGmbH, Austria It will be followed by the panel discussion moderated by Andreas Falk, CEO of BNN.
Two important concepts will be introduced: Safety-and-Sustainability-by-design - a cornerstone for sustainable innovation by Susanne Resch, BNN (BioNanoNet ForschungsGmbH), Austria and Open innovation test beds - their role on the way to the market by two existing infrastructures: - PHOENIX - Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products (10 minutes) Scientific Coordinator Dr. Nazende Günday-Türeli, MyBiotech GmbH, Germany - NextGenMicrofluidics - Next generation test bed for upscaling of microfluidic devices based on nano-enabled surfaces and membranes (10 minutes) Scientific Coordinator Dr. Martin Smolka, JOANNEUM RESEARCH ForschungsGmbH, Austria It will be followed by the panel discussion moderated by Andreas Falk, CEO of BNN.